Schrödinger Inc SDGR shares are trading higher by 4.8% at $62.58 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and announced an $82 price target.
Schrödinger shares were trading lower last month after the company reported worse-than-expected second-quarter EPS and sales results. The company also issued FY21 sales guidance with a midpoint below analyst estimates.
Schrödinger is a healthcare-based software company. Schrödinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
Schrödinger has a 52-week high of $117.00 and a 52-week low of $46.27.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
